Advertisement
Screener

Omagine, Inc. Form 8-K: Current report, 2017

Omagine, Inc. Form 8-K: Current report

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2017-10-19: Form 8-K; Period of report 2017-10-06; Description 1.01 Entry into a Material Definitive Agreement; 8.01 Other Events; Details 1.01.
  • 2017-10-18: Form 8-K; Period of report 2017-09-28; Description 1.01 Entry into a Material Definitive Agreement; Details 1.01.
  • 2017-02-06: Form 8-K; Period of report 2017-02-02; Description 3.02 Unregistered Sales of Equity Securities; Details 3.02.
  • 2017-02-02: Form 8-K; Period of report 2017-02-01; Description 3.02 Unregistered Sales of Equity Securities; Details 3.02.
FiledFormPeriod of reportDescriptionDetailsDocument
2017-10-198-K2017-10-061.01 Entry into a Material Definitive Agreement; 8.01 Other Events1.01 Omagine, Inc. (the ”Company”) and Auctus Fund, LLC (“Auctus”), an accredited investor, entered into a convertible promissory note dated October 6, 2017 (the “Auctus Convertible Note” or the “Note”) for the principal amount of $57,750.
8.01 Further to its continuing efforts to maximize clarity and transparency for its shareholders with respect to some inherently complex matters, the Company is providing the following information.
f8k100617_omagineinc.htm
2017-10-188-K2017-09-281.01 Entry into a Material Definitive Agreement1.01 Omagine, Inc. (the ”Company”) and EMA Financial, LLC (“EMA”), an accredited investor, entered into a convertible promissory note dated September 28, 2017 (the “EMA Convertible Note” or the “Note”) for the principal amount of $55,000.f8k092817_omagineinc.htm
2017-02-068-K2017-02-023.02 Unregistered Sales of Equity Securities3.02 On February 2, 2017, the Company’s three independent directors, Alan M. Matus (“Matus”), Jack A. Smith (“Smith”) and Louis J. Lombardo (“Lombardo”) and the Company’s Vice President, Charles P. Kuczynski (“Kuczynski”) purchased from the Company the aggregate of 330,190 restricted shares of the Company’s common stock (the “Restricted Shares”) at a price of $0.53 per share.f8k020217_omagine.htm
2017-02-028-K2017-02-013.02 Unregistered Sales of Equity Securities3.02 On February 1, 2017, Frank J. Drohan (“Drohan”) the president of Omagine Inc. (the “Company”) purchased from the Company 100,000 restricted shares of the Company’s common stock (the “Restricted Shares”) at a price of $0.51 per share.f8k020117_omagine.htm